TROFOSFAMIDE for Metastatic malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where TROFOSFAMIDE was used for Metastatic malignant melanoma.
Most Reported Side Effects for TROFOSFAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute myeloid leukaemia | 18 | 16.5% | 9 | 1 |
| Myelodysplastic syndrome | 18 | 16.5% | 9 | 1 |
| Product use in unapproved indication | 16 | 14.7% | 0 | 2 |
| Off label use | 15 | 13.8% | 2 | 1 |
| Neutropenia | 14 | 12.8% | 1 | 6 |
| Anaemia | 13 | 11.9% | 0 | 0 |
| Dyspnoea | 12 | 11.0% | 0 | 7 |
| Oedema | 10 | 9.2% | 0 | 0 |
| Pleural effusion | 10 | 9.2% | 0 | 5 |
| Hepatosplenomegaly | 9 | 8.3% | 0 | 0 |
| Hyperleukocytosis | 9 | 8.3% | 1 | 0 |
| Rhabdomyosarcoma recurrent | 9 | 8.3% | 2 | 0 |
| Thrombocytopenia | 9 | 8.3% | 0 | 0 |
| Neoplasm progression | 8 | 7.3% | 2 | 0 |
| Acute kidney injury | 7 | 6.4% | 1 | 5 |
Other Indications for TROFOSFAMIDE
Diffuse large b-cell lymphoma (13)
Alveolar rhabdomyosarcoma (12)
Langerhans' cell histiocytosis (11)
Angioimmunoblastic t-cell lymphoma (6)
Product used for unknown indication (6)
Hodgkin's disease (5)
Lymphoma (5)
Other Drugs Used for Metastatic malignant melanoma
NIVOLUMAB (4,628)
IPILIMUMAB (4,430)
DABRAFENIB (3,885)
PEMBROLIZUMAB (2,742)
TRAMETINIB DIMETHYL SULFOXIDE (2,031)
VEMURAFENIB (1,848)
TRAMETINIB (1,604)
COBIMETINIB (898)
ENCORAFENIB (865)
BINIMETINIB (841)